Imidazolo-related compounds, compositions and methods for their use

Details for Australian Patent Application No. 2005260629 (hide)

Owner Amgen SF, LLC

Inventors Marcus, Andrew P.; Du, Xiaohui; Duquette, Jason A.; Chen, Xiaoqi; Li, AnRong; Bergeron, Philippe; Johnson, Michael G.; Medina, Julio C.; Deignan, Jeffrey; Gustin, Darin; Mihalic, Jeffrey T.; Fu, Zice

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2005260629

PCT Pub. Number WO2006/004924

Priority 60/583,822 28.06.04 US

Filing date 28 June 2005

Wipo publication date 12 January 2006

International Classifications

C07D 235/00 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

A61K 31/4164 (2006.01) - 1,3-Diazoles

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

C07D 233/54 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

C07D 235/14 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/04 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

Event Publications

15 February 2007 PCT application entered the National Phase

  PCT publication WO2006/004924 Priority application(s): WO2006/004924

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005260630-Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido(2,3-D)pyrimidin-4(3H)-one-rel ated compounds, compositions and methods for their use

2005260620-Fused pyrimidine derivatives and compositions thereof as CXCR3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases